US Patent Issued to ONCOGREEN THERAPEUTICS on June 2 for "Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors" (Italian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,841, issued on June 2, was assigned to ONCOGREEN THERAPEUTICS SA (Lugano, Switzerland).

"Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors" was invented by Andrea Carpi (Brendola, Italy), Fabio Maset (Brendola, Italy) and Renzo Dal Monte (Brendola, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new ligands of the follicle stimulating hormone (FSH) receptor for use in the diagnosis and treatment of neuroblastoma."

The patent was filed on Oct. 10, 2017, under Application No. 16/340,876.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/...